| AASLD

¡Ya no más EHGNA! En nuestra lengua Esteatosis Hepatica es el nuevo término general. Y se crea la nueva nomenclatura Esteatosis Hepática Metabólica (MASLD).

Pari M. Shah

Read more about Pari M. Shah

Memorial Sloan Kettering Cancer Center

AASLD Foundation Funds $2 Million in Liver Research and Career Development Grants in 2023

Read more about AASLD Foundation Funds $2 Million in Liver Research and Career Development Grants in 2023

Alexandria, VA – The American Association for the Study of Liver Diseases (AASLD) Foundation, the largest medical society...

Steatotic Liver Disease Nomenclature Implementation Symposium

Read more about Steatotic Liver Disease Nomenclature Implementation Symposium

90 minute: Talks + Panel Discussion

Non-Invasive Tests for MASLD/MASH: Moving the Field Forward

Read more about Non-Invasive Tests for MASLD/MASH: Moving the Field Forward

This session delves into the progress in diagnosing At-Risk-MASH, with discussions on the viability of achieving MASH resolution through drug development and the potential of non-invasive tests (NITs) for outcome prediction. The session also explores a Ph